The global miRNA tools and services market was valued $311.86 million in 2021 and expected to reach $1,822.15 million by 2031, with a CAGR of 19.3% from 2022 to 2031. After the process of transcription, the molecules that regulate gene expressions are microRNAs (miRNAs). MiRNAs are a type of non-coding RNA. MiRNAs have been found in a variety of organs and extracellularly in bio fluids such serum, plasma, saliva, and urine. Because miRNAs are highly stable in samples like FFPE, plasma, and serum, they can be used to generate biomarkers and clinical diagnostics. MicroRNA (miRNA) is a type of noncoding RNA with a length of 22nt that is responsible for RNA silencing and post-transcriptional regulation of gene expression in numerous cancer cells at the same time. Base-pairing with complementary sequences within mRNA molecules is how they work. They've recently been studied as novel therapeutic agents for treating a variety of illnesses, including cancer and infections.
Development of new product tools is one of the most important recent advancements in the miRNA market. Nano String Technologies Inc., for example, launched the GeoMx Digital Spatial Profiler in 2020, which allowed for highly-multiplexed spatial profiling of RNA and protein targets in a range of sample types, including FFPE tissue sections.
Recent advancements in microRNA applications, such as possible biomarkers in sophisticated diagnostics, have accelerated the development of new products and research in exploration of miRNA are all factors that drive the growth of miRNA tools and services market. The formation of massive amounts of public and private money is one of the primary factors contributing to market expansion. Advantages of miRNA sequencing over other technologies, increase in development of genomics products, and decline in the falling cost of sequencing are all driving this market forward. However, the inconvenient nature of microRNAs' development is exacerbated by their complexity and fragility. Furthermore, the market is expected to flourish by bioinformatics and technologically improved systems, such as Next-Generation Sequencing.
The miRNA tools and services market is segmented on the basis of product, technology, end user, and region. By product, the industry classified into research tools and services. The research tools segment is further segmented into kits, reagents, and other consumables, and services segment is fragmented into miRNA extraction services, quantification services, microarray services, sequencing services, functional studies services, and others. By technology the market is segregated into extraction tools, qrt-pcr, next-generation sequencing, microarray, functional analysis tools and others.
By end user, the market is classified into research & academic institutes, in vitro diagnostics, pharma & biotech companies, and contract research organizations s. Region wise, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
Major key players that operate in the global miRNA tools and services market are Agilent Technologies, Bio-Rad laboratories, General Electrics, Integrated DNA Technologies, Koninklijike Philips N.V., Merck & Co., Omega Bio-Tek, Promega Corporation, Qiagen, and Thermo Fischer Scientific Inc.
Development of new product tools is one of the most important recent advancements in the miRNA market. Nano String Technologies Inc., for example, launched the GeoMx Digital Spatial Profiler in 2020, which allowed for highly-multiplexed spatial profiling of RNA and protein targets in a range of sample types, including FFPE tissue sections.
Recent advancements in microRNA applications, such as possible biomarkers in sophisticated diagnostics, have accelerated the development of new products and research in exploration of miRNA are all factors that drive the growth of miRNA tools and services market. The formation of massive amounts of public and private money is one of the primary factors contributing to market expansion. Advantages of miRNA sequencing over other technologies, increase in development of genomics products, and decline in the falling cost of sequencing are all driving this market forward. However, the inconvenient nature of microRNAs' development is exacerbated by their complexity and fragility. Furthermore, the market is expected to flourish by bioinformatics and technologically improved systems, such as Next-Generation Sequencing.
The miRNA tools and services market is segmented on the basis of product, technology, end user, and region. By product, the industry classified into research tools and services. The research tools segment is further segmented into kits, reagents, and other consumables, and services segment is fragmented into miRNA extraction services, quantification services, microarray services, sequencing services, functional studies services, and others. By technology the market is segregated into extraction tools, qrt-pcr, next-generation sequencing, microarray, functional analysis tools and others.
By end user, the market is classified into research & academic institutes, in vitro diagnostics, pharma & biotech companies, and contract research organizations s. Region wise, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
Major key players that operate in the global miRNA tools and services market are Agilent Technologies, Bio-Rad laboratories, General Electrics, Integrated DNA Technologies, Koninklijike Philips N.V., Merck & Co., Omega Bio-Tek, Promega Corporation, Qiagen, and Thermo Fischer Scientific Inc.
Key Benefits For Stakeholders
- This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the mirna tools and services market analysis from 2021 to 2031 to identify the prevailing miRNA tools and services market opportunity.
- The market research is offered along with information related to key drivers, restraints, and opportunities.
- Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
- In-depth analysis of the mirna tools and services market segmentation assists to determine the prevailing market opportunities.
- Major countries in each region are mapped according to their revenue contribution to the global market.
- Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
- The report includes the analysis of the regional as well as global mirna tools and services market trends, key players, market segments, application areas, and market growth strategies.
Key Market Segments
By Product and Services
- Research Tools
- Services
By Technology
- Extraction Tools
- qRT-PCR
- NGS
- Microarray
- Functional Analysis Tools
- Others
By End User
- Research and Academic Institutes
- IVD, Pharma and Biotech Companies
- CROs
By Region
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Spain
- Rest of Europe
- Asia-Pacific
- Japan
- China
- Australia
- India
- South Korea
- Rest of Asia-Pacific
- LAMEA
- Brazil
- Saudi Arabia
- South Africa
- Rest of LAMEA
Key Market Players
- Agilent Technologies INC.
- Bio-Rad Laboratories, Inc.
- GeneCopoeia, Inc.
- Illumina, Inc.
- New England Biolabs
- Norgen Biotek Corp.
- Promega Corporation
- Qiagen N.V.
- Thermo Fisher Scientific inc
- General Electric Company
Please note:
- Online Access price format is valid for 60 days access. Printing is not enabled.
- PDF Single and Enterprise price formats enable printing.
Table of Contents
CHAPTER 1: INTRODUCTION
CHAPTER 2: EXECUTIVE SUMMARY
CHAPTER 3: MARKET OVERVIEW
CHAPTER 4: MIRNA TOOLS AND SERVICES MARKET, BY PRODUCT AND SERVICES
CHAPTER 5: MIRNA TOOLS AND SERVICES MARKET, BY TECHNOLOGY
CHAPTER 6: MIRNA TOOLS AND SERVICES MARKET, BY END USER
CHAPTER 7: MIRNA TOOLS AND SERVICES MARKET, BY REGION
CHAPTER 8: COMPANY LANDSCAPE
CHAPTER 9: COMPANY PROFILES
LIST OF TABLES
LIST OF FIGURES
Executive Summary
According to this report titled, 'MiRNA Tools and Services Market,' the mirna tools and services market was valued at $311.86 million in 2021, and is estimated to reach $1.8 billion by 2031, growing at a CAGR of 19.3% from 2022 to 2031.All eukaryotic cells have micro-RNA as a genetic component. These are essential components of gene expression in both animal and plant cells, and thus essential for normal cell function. RNA interference drug development and therapies are important for microRNA since the goal of RNA-targeted research is to regulate and control gene expression. Long-term incurable diseases like AIDS and cancer have been linked to abnormal gene expression in recent studies. Micro-RNA research could possibly provide a solution to one of medicine's most vexing difficulties.
The major factors that drive global miRNA tools and services market are rise in the adoption of miRNA instruments and consumables, which is expected to be aided by extensive research activities aimed at determining the possible functions of microRNA (miRNA) in the development of novel therapeutic treatments for a variety of disorders. These investigations aid in understanding the signaling pathway's mechanism of action, which is crucial for developing miRNA therapeutic candidates. For example, Munich researchers revealed in June 2020 that a certain microRNA helps to maintain the integrity of the endothelium, lowering the risk of atherosclerosis. The inflow of miRNA research is being fueled by strong funding in biotechnology companies that offer miRNA treatments. For example, InteRNA Technologies obtained22.46 million in a series B fundraising round sponsored by AurorA Science, an Italian biotech investment firm, in February 2021. Furthermore, investigations have revealed that these miRNAs play a role in the host's response to coronavirus and other respiratory viruses. As a result, utilizing sequencing tools to analyze variations in miRNA expressions will help researchers better understand the pathophysiology of chronic respiratory infections.
The market is expected to witness significant growth owing to the rise in incidence of cancer and cardiovascular diseases. Moreover, use of bioinformatics and technologically advanced systems (such as NGS) are set to drive the market growth and the potential of miRNAs to act as candidates for diagnostic biomarkers are anticipated to further contribute to the demand for miRNA globally. However, the challenges related to quantification and the development of in-house miRNA research tools such as microarrays are expected to impede the market growth.
Technological developments are a new trend in Micro RNA research, resulting in significant progress in miRNA technology. In recent years, manufacturers and researchers have been inspired to develop new solutions due to increased technological improvements in the essential phases of miRNA expression profiling, target gene identification, and validation. HTG Molecular Diagnostics Inc, for example, launched a comprehensive panel for miRNA expression analysis, the HTG EdgeSeq mouse miRNA whole transcriptome test, in August 2018, for use in preclinical functional investigations and translational medicine. Furthermore, continuing research and clinical trials for miRNA broaden its clinical and preclinical research uses. A rising body of evidence suggests that miRNAs have great utility as drug resistance modulators, biomarkers for pathogenic diseases, or medicines for medical intervention in human health disorders. As a result, increasing the number of clinical trials for evaluating the efficacy of miRNA in the treatment of many chronic illnesses is one of the significant factors fueling the growth of the miRNA market throughout the forecast period.
The miRNA tools and services industry is segmented on the basis of product, technology, end user, and region. By product, the miRNA tools and services market share is segmented into research tools and services. The research tools segment is further segmented into kits, reagents, and other consumables and services segment is fragmented into miRNA extraction services, quantification services, microarray services, sequencing services, functional studies services, and others. The research tools segment dominated the market in 2021 with a revenue of $252.62 million. Growth of the segment is attributed to increasing incidence of chronic diseases such as cancer and cardiovascular disorders, research funding by various companies and recent developments such as use of bioinformatics for the research has further driven the market growth. By technology type, the market is classified into extraction tools, qrt-pcr, next-generation sequencing, microarray, functional analysis tools and others. The qRT-PCR segment dominated the market in 2021 with a revenue of $93.49 million. The growth of the segment in miRNA tools and services market trends can be attributed to surge in in the incidence of chronic diseases, rise in the number of cancer cases, increase in funding in gene manipulation therapies research& innovative drug development methodologies that use RNAi-based approaches.
By end user type, the market is classified into research & academic institutes, In vitro diagnostics, pharma & biotech companies, and contract research organizations The research & academic institutes segment dominated the market in 2021 with a revenue of $142.74 million.
KEY FINDINGS OF STUDY
- The study provides an in-depth analysis of the miRNA tools and services market size along with the current trends and future estimations to elucidate the imminent investment pockets.
- It offers miRNA tools and services market analysis from 2021 to 2031, which is expected to enable the stakeholders to capitalize on the prevailing opportunities in the market.
- A comprehensive analysis of four regions is provided to determine the prevailing opportunities.
- The profiles and growth strategies of the key players are thoroughly analysed to understand the competitive outlook and global miRNA tools and services market growth.
Companies Mentioned
- Agilent Technologies INC.
- Bio-Rad Laboratories, Inc.
- GeneCopoeia, Inc.
- Illumina, Inc.
- New England Biolabs
- Norgen Biotek Corp.
- Promega Corporation
- Qiagen N.V.
- Thermo Fisher Scientific inc
- General Electric Company
Methodology
The analyst offers exhaustive research and analysis based on a wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics, and regional intelligence. The in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. The primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions.
They are also in professional corporate relations with various companies that allow them greater flexibility for reaching out to industry participants and commentators for interviews and discussions.
They also refer to a broad array of industry sources for their secondary research, which typically include; however, not limited to:
- Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
- Scientific and technical writings for product information and related preemptions
- Regional government and statistical databases for macro analysis
- Authentic news articles and other related releases for market evaluation
- Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecast
Furthermore, the accuracy of the data will be analyzed and validated by conducting additional primaries with various industry experts and KOLs. They also provide robust post-sales support to clients.
LOADING...
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 205 |
| Published | May 2022 |
| Forecast Period | 2021 - 2031 |
| Estimated Market Value ( USD | $ 311.86 million |
| Forecasted Market Value ( USD | $ 1822.15 million |
| Compound Annual Growth Rate | 19.3% |
| Regions Covered | Global |
| No. of Companies Mentioned | 10 |
